These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29016350)
1. A novel design of HA-coated nanoparticles co-encapsulating plasmid METase and 5-Fu shows enhanced application in targeting gastric cancer stem cells. Yang W; Zhang H; Xin L Biol Chem; 2018 Feb; 399(3):293-303. PubMed ID: 29016350 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells. Li YF; Zhang HT; Xin L J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma. Xin L; Zhang HT; Yang WF; Li YF; Liu C Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29229675 [TBL] [Abstract][Full Text] [Related]
4. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related]
5. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer. Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930 [TBL] [Abstract][Full Text] [Related]
6. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy. Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667 [TBL] [Abstract][Full Text] [Related]
7. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Yang F; Li A; Liu H; Zhang H Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. Wang T; Hou J; Su C; Zhao L; Shi Y J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles. Russo A; Maiolino S; Pagliara V; Ungaro F; Tatangelo F; Leone A; Scalia G; Budillon A; Quaglia F; Russo G Oncotarget; 2016 Nov; 7(48):79670-79687. PubMed ID: 27835895 [TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation. Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells. Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649 [TBL] [Abstract][Full Text] [Related]
13. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine. Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186 [TBL] [Abstract][Full Text] [Related]
14. [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles]. Huang KH; Liu JH; Wang LY; Zhu ZH; Chen QK; Min J; Chen RF Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):482-5. PubMed ID: 17851795 [TBL] [Abstract][Full Text] [Related]
15. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer. Jung YS; Koo DH; Yang JY; Lee HY; Park JH; Park JH Drug Deliv; 2018 Nov; 25(1):872-879. PubMed ID: 29608119 [TBL] [Abstract][Full Text] [Related]
16. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects. Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo. Cheng M; Ma D; Zhi K; Liu B; Zhu W Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma. Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Wang J; Liu W; Zhao Q; Qi Q; Lu N; Yang Y; Nei FF; Rong JJ; You QD; Guo QL Toxicology; 2009 Feb; 256(1-2):135-40. PubMed ID: 19084572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]